All News

Multiple large-scale studies have suggested that menopause is a sex-specific risk factor for cognitive dysfunction independent of aging and other menopause symptoms, such as depression, anxiety, and hot flashes.

Macrophages could be critical treatment targets because they could be infected by SARS-CoV-2 and can contribute to spreading the infection through the lung.

The FDA approved Enhertu in January 2020 for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.

The right balance of stem cell dose, cell type, and timing of antiretroviral therapy (ART) could potentially lead to a spontaneous cure of HIV, according to the study authors.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Daratumumab and hyaluronidase-fihj, a subcutaneous formulation of daratumumab, is the first FDA-approved treatment for patients with AL amyloidosis.

A new study suggests abnormal sleep architecture can be a predictor of stress.

A survey found that the majority of oncologists did not feel like they could perform their duties as well as they could prior to the COVID-19 pandemic.

The study authors note that COVID-19 disease processes could predispose patients to a higher burden of acute brain dysfunction.

B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.

The changes, finalized today, are generally effective for the 2022 plan year and will potentially lower enrollee cost sharing on some of the most expensive prescription drugs.

Crizotinib is the first biomarker-driven therapy for relapsed or refractory anaplastic large cell lymphoma in children and young adults.

Recent surveys indicate that the proportion of the US population willing to be vaccinated for COVID-19 has fluctuated from 72% in May to 51% in September 2020.

The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.

In a statement by the APhA, Scott J. Knoer, executive vice president and CEO of APhA, noted the association’s support for this first step by the Biden administration on the road to recovery from the pandemic.

Participants with severe withdrawal symptoms were more likely to be younger, longtime and frequent users of cannabis, and to have worse mental health.

Novel program found cost effective and safe for patients with cancer managing the adverse effects of treatment.

New research suggests immunosuppressants do not increase the risk of worse COVID-19 outcomes.

In a statement released by NCPA, the association explained that the current COVID-19 vaccination rollout in the country could be accelerated by working with community pharmacists.

This medicinal beverage was believed to be an effective treatment for hypothermia, which earned it regular passage on many of the early expeditions to the Arctic.

Financial support benefits Red Cross mission in Southern California and beyond.

The single dose investigational vaccine being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson is a recombinant, replication-incompetent adenovirus serotype 26 vector encoding a stabilized SARS-CoV-2 spike protein.

The symptoms of depression in caregivers of patients with dementia exacerbates over time.

As new testing devices, therapies, and vaccines are approved for COVID-19, patients will be dependent on their health care providers for answers and education.

Diabetes and stress-induced hyperglycemia affect an estimated 30% to 45% of all hospitalized patients.

The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.

The new research shows that adolescents are 9 times more likely to receive a vaccine when providers introduce the topic to parents with a simple statement such as “your child is due for vaccines today,” as it results in a shorter vaccine discussion.

For patients with COVID-19, mitochondria are one of the first lines of defense in fighting the virus.

Although only a proportion of DCIS cases will progress into invasive cancer, the treatments available for DCIS are similar to treatments for invasive breast cancers.

Smoking was associated with not only a greater risk of disease, but also an increased risk of severe COVID-19.